Search: onr:"swepub:oai:DiVA.org:oru-102266" >
Association of lymp...
-
Daskalakis, Kosmas,1979-Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,Second Department of Surgery, "Korgialenio-Benakio", Red Cross General Hospital, Athens, Greece
(author)
Association of lymph node metastases, grade and extent of mesenteric lymph node dissection in locoregional small intestinal neuroendocrine tumors with recurrence-free survival
- Article/chapterEnglish2022
Publisher, publication year, extent ...
-
2022-11-17
-
Wiley-Blackwell Publishing Inc.2022
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:oru-102266
-
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-102266URI
-
https://doi.org/10.1111/jne.13205DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
We aimed to assess the prognostic impact of tumor- and patient-related parameters in patients with stage I-III small intestinal neuroendocrine tumors (SI-NETs), who underwent locoregional resective surgery (LRS) with curative intent. We included 229 patients with stage I-III SI-NETs diagnosed from June 15, 1993, through March 8, 2021, identified using the SI-NET databases from five European referral centers. Mean ± SD age at baseline was 62.5 ± 13.6 years; 111/229 patients were women (49.3%). All tumors were well-differentiated; 160 were grade 1 (G1) tumors, 51 were G2, two were G3 and 18 tumors were of unspecified grade (median Ki-67: 2%, range 1%-50%). One-hundred and sixty-three patients (71.2%) had lymph node (LN) involvement. The median number of retrieved lymph nodes was 10 (0-63), whereas the median number of positive LNs was 2 (0-43). After a mean ± SD follow-up of 54.1 ± 64.1 months, 60 patients experienced disease recurrence at a median (range) of 36.2 (2.5-285.1) months. The 5- and 10-year recurrence-free survival (RFS) rates were 66.6% and 49.3% respectively. In univariable analysis, there was no difference in RFS and overall survival (OS) between LN-positive and LN-negative patients (log-rank, p = .380 and .198, respectively). However, in stage IIIb patients who underwent mesenteric lymph node dissection (MLND) with a minimum of five retrieved LN (n = 125), five or more LN metastases were associated with shorter RFS (median RFS [95% CI] = 107.4 [0-229.6] vs. 73.7 [35.3-112.1] months; log-rank, p = .048). In addition, patients with G2 tumors exhibited shorter RFS compared to patients with G1 tumors (median RFS [95% confidence interval (CI)] = 46.9 [36.4-57.3] vs. 120.7 [82.7-158.8] months; log-rank, p = .001). In multivariable Cox-regression RFS analysis in stage IIIb patients, the Ki-67 proliferation index (hazard ratio = 1.08, 95% CI = 1.035-1.131; p < .0001) and the number of LN metastases (hazard ratio = 1.06, 95% CI = 1.001-1.125; p = .047) were independent prognostic factors for RFS. In conclusion, LRS with a meticulous MLND and a minimum number of five harvested LNs appears to be critical in the surgical management of SI-NET patients with locoregional disease. In patients who underwent LRS and MLND, the Ki-67 proliferation index and the LN metastases count were independent predictors of RFS.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Wedin, Maria,1977-Örebro universitet,Institutionen för medicinska vetenskaper,Department of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden(Swepub:oru)mrwn
(author)
-
Tsoli, MarinaEndocrine Oncology Unit, First Department of Propaupedic Internal Medicine, Laiko Hospital, National and Kapodistrian University of Athens, Athens, Greece
(author)
-
Kogut, AngelikaDepartment of Endocrinology and Neuroendocrine Neoplasms, Department of Endocrinology and Pathophysiology, Medical University of Silesia, Katowice, Poland
(author)
-
Srirajaskanthan, RajENETS Centre of Excellence, Neuroendocrine Tumour Unit, King's College Hospital, London, UK; Department of Gastroenterology, King's College Hospital, London, UK
(author)
-
Sarras, KonstantinosDepartment of Gastroenterology, King's College Hospital, London, UK
(author)
-
Kattiparambil, SajithDepartment of Gastroenterology, King's College Hospital, London, UK
(author)
-
Giovos, GeorgeThe ARDEN NET Centre, European Neuroendocrine Tumour Society (ENETS) Centre of Excellence (CoE), University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK
(author)
-
Weickert, Martin O.The ARDEN NET Centre, European Neuroendocrine Tumour Society (ENETS) Centre of Excellence (CoE), University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK
(author)
-
Kos-Kudla, BeataDepartment of Endocrinology and Neuroendocrine Neoplasms, Department of Endocrinology and Pathophysiology, Medical University of Silesia, Katowice, Poland
(author)
-
Kaltsas, GregoryEndocrine Oncology Unit, First Department of Propaupedic Internal Medicine, Laiko Hospital, National and Kapodistrian University of Athens, Athens, Greece
(author)
-
Örebro universitetInstitutionen för medicinska vetenskaper
(creator_code:org_t)
Related titles
-
In:Journal of neuroendocrinology: Wiley-Blackwell Publishing Inc.34:110953-81941365-2826
Internet link
Find in a library
To the university's database
- By the author/editor
-
Daskalakis, Kosm ...
-
Wedin, Maria, 19 ...
-
Tsoli, Marina
-
Kogut, Angelika
-
Srirajaskanthan, ...
-
Sarras, Konstant ...
-
show more...
-
Kattiparambil, S ...
-
Giovos, George
-
Weickert, Martin ...
-
Kos-Kudla, Beata
-
Kaltsas, Gregory
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Surgery
- Articles in the publication
-
Journal of neuro ...
- By the university
-
Örebro University